Published in Arch Neurol on September 01, 2001
Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study | NCT04080544
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Alzheimer's disease: the challenge of the second century. Sci Transl Med (2011) 4.88
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol (2009) 4.71
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol (2009) 4.55
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med (2009) 4.11
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology (2009) 3.72
Neural mechanisms of ageing and cognitive decline. Nature (2010) 3.59
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging (2005) 3.32
Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med (2011) 3.28
Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease. EMBO Mol Med (2009) 2.87
MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology (2009) 2.83
High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment. Neuroimage (2010) 2.62
Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging (2006) 2.48
Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci U S A (2004) 2.39
Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging (2009) 2.14
Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area. Neurobiol Aging (2007) 2.09
MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology (2011) 2.08
Active and passive immunotherapy for neurodegenerative disorders. Annu Rev Neurosci (2008) 2.01
Changes in the structural complexity of the aged brain. Aging Cell (2007) 1.96
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Atrophy rates of entorhinal cortex in AD and normal aging. Neurology (2003) 1.88
Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A (2003) 1.86
Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain (2006) 1.86
Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging (2005) 1.83
Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav (2010) 1.80
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age. JAMA Neurol (2015) 1.70
Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci (2008) 1.64
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity. JAMA Neurol (2013) 1.60
Role of presenilins in neuronal calcium homeostasis. J Neurosci (2010) 1.59
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx (2005) 1.58
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease. Neuroimage (2009) 1.55
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI. Hum Brain Mapp (2011) 1.53
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology (2013) 1.51
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol (2011) 1.51
Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage (2008) 1.49
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimers Res Ther (2013) 1.44
Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data. Ann Neurol (2011) 1.40
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci U S A (2006) 1.34
Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging (2007) 1.34
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34
Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2006) 1.33
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One (2011) 1.32
Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia. Arch Neurol (2012) 1.29
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis (2010) 1.28
Pathogenesis of Alzheimer's disease. Clin Interv Aging (2007) 1.27
Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med (2008) 1.24
Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am J Pathol (2008) 1.22
Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol (2011) 1.20
The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. J Alzheimers Dis (2010) 1.19
Toward a multifactorial model of Alzheimer disease. Neurobiol Aging (2012) 1.16
CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology (2012) 1.13
Biomarkers in translational research of Alzheimer's disease. Neuropharmacology (2010) 1.11
Histology-derived volumetric annotation of the human hippocampal subfields in postmortem MRI. Neuroimage (2013) 1.10
Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2011) 1.09
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med (2012) 1.07
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J Neurol (2006) 1.07
Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. Neurobiol Aging (2007) 1.06
Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther (2011) 1.05
Memory after silent stroke: hippocampus and infarcts both matter. Neurology (2012) 1.05
Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol (2010) 1.04
Cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med (2010) 1.03
Neuroinflammation and memory: the role of prostaglandins. Mol Neurobiol (2009) 1.02
Spatial pattern separation in cognitively normal young and older adults. Hippocampus (2012) 1.02
Region specific neuron loss in the aged canine hippocampus is reduced by enrichment. Neurobiol Aging (2006) 1.01
Episodic memory on the path to Alzheimer's disease. Curr Opin Neurobiol (2011) 1.01
7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS One (2014) 1.01
Lateral entorhinal cortex is critical for novel object-context recognition. Hippocampus (2013) 1.00
Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci (2010) 0.98
Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention. CNS Neurol Disord Drug Targets (2009) 0.97
Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting. Hum Brain Mapp (2014) 0.97
Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability. Curr Genomics (2010) 0.97
Neuronal and morphological bases of cognitive decline in aged rhesus monkeys. Age (Dordr) (2011) 0.97
Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia. Front Aging Neurosci (2014) 0.96
Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis (2010) 0.95
Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease. Ageing Res Rev (2013) 0.95
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. JAMA Neurol (2015) 0.94
Whole brain N-acetylaspartate concentration is conserved throughout normal aging. Neurobiol Aging (2012) 0.93
Enrichment and stratification for predementia Alzheimer disease clinical trials. PLoS One (2012) 0.93
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease. Mol Med (2011) 0.90
Brain aging in the oldest-old. Curr Gerontol Geriatr Res (2010) 0.90
Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation. PLoS One (2013) 0.90
Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimers Dement (Amst) (2015) 0.90
Caspase-6 activity predicts lower episodic memory ability in aged individuals. Neurobiol Aging (2013) 0.90
Less efficient pattern separation may contribute to age-related spatial memory deficits. Front Aging Neurosci (2012) 0.90
The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy. PLoS One (2015) 0.89
Lateral entorhinal cortex is necessary for associative but not nonassociative recognition memory. Hippocampus (2013) 0.89
Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy. PLoS One (2013) 0.87
Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. Nat Rev Drug Discov (2011) 0.87
PET amyloid-beta imaging in preclinical Alzheimer's disease. Biochim Biophys Acta (2011) 0.87
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Psychopharmacology (Berl) (2008) 0.86
Mild cognitive impairment: historical development and summary of research. Dialogues Clin Neurosci (2004) 0.86
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging (2011) 0.86
Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease. PLoS One (2014) 0.85
Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample. J Alzheimers Dis (2012) 0.85
Is there a neuropathology difference between mild cognitive impairment and dementia? Dialogues Clin Neurosci (2009) 0.85
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol (1999) 10.45
Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol (2001) 8.88
Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci (1996) 7.19
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol (1998) 5.93
Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters. J Biol Chem (2000) 4.96
Cancer linked to Alzheimer disease but not vascular dementia. Neurology (2009) 4.83
Evolutionary consequences of indirect genetic effects. Trends Ecol Evol (1998) 4.78
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07
Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol (2004) 3.84
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 3.77
The AD8: a brief informant interview to detect dementia. Neurology (2005) 3.65
Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology (2005) 3.55
Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology (2001) 3.30
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology (1996) 3.29
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage (2005) 3.21
A longitudinal study of drivers with Alzheimer disease. Neurology (2008) 3.17
Functional brain imaging of young, nondemented, and demented older adults. J Cogn Neurosci (2000) 3.12
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology (2000) 2.99
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging (1992) 2.97
Protection against Alzheimer's disease with apoE epsilon 2. Lancet (1994) 2.96
American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. Neurology (2007) 2.79
Preparation and characterization of a plasma membrane fraction from isolated fat cells. J Cell Biol (1970) 2.53
Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology (1991) 2.53
Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull (1988) 2.50
Reliability of the Washington University Clinical Dementia Rating. Arch Neurol (1988) 2.48
Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol (1988) 2.38
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology (2001) 2.38
Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology (2000) 2.31
A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol (1998) 2.22
Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology (2004) 2.20
Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology (1997) 2.13
The value of informant versus individual's complaints of memory impairment in early dementia. Neurology (2000) 2.10
Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc (2001) 2.10
Novel use of the Rendell-Baker Soucek mask. Anaesthesia (1991) 2.02
Mechanisms underlying generation of gradients in gene expression within the intestine: an analysis using transgenic mice containing fatty acid binding protein-human growth hormone fusion genes. Genes Dev (1988) 2.01
Optimal use of blood tests for assessment of thyroid function. JAMA (1993) 2.00
Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem (2001) 1.98
Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol (1997) 1.98
Microorganism mediated reproductive isolation in flour beetles (genus Tribolium). Science (1985) 1.93
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology (2004) 1.92
Group selections among laboratory populations of Tribolium. Proc Natl Acad Sci U S A (1976) 1.91
The joint effects of kin, multilevel selection and indirect genetic effects on response to genetic selection. J Evol Biol (2008) 1.91
Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. J Clin Microbiol (2001) 1.91
Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol (1990) 1.89
Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans. Infect Immun (2001) 1.89
Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology (1998) 1.85
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology (2009) 1.85
Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology (2011) 1.84
Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. Arch Neurol (1997) 1.84
Geographic and genetic variation in death-feigning behavior in the flour beetle, Tribolium castaneum. Behav Genet (1981) 1.82
Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology (2000) 1.82
Kin selection: its components. Science (1980) 1.81
Cytoplasmically inherited reproductive incompatibility in Tribolium flour beetles: the rate of spread and effect on population size. Genetics (1990) 1.79
Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol (1994) 1.77
Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet (1999) 1.73
Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yield comparable diagnostic results. Alzheimer Dis Assoc Disord (1993) 1.72
Brief screening tests versus clinical staging in senile dementia of the Alzheimer type. J Am Geriatr Soc (1990) 1.69
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66
A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet (1998) 1.63
Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging. Neurology (2008) 1.62
Alzheimer disease and cancer. Neurology (2005) 1.60
Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology (1996) 1.59
Current concepts in the pathogenesis of Alzheimer's disease. Am J Med (1997) 1.58
Referral pattern of leptospirosis cases during a large urban epidemic of dengue. Am J Trop Med Hyg (2001) 1.52
The role of catheter composition in the development of thrombophlebitis. Surg Gynecol Obstet (1974) 1.51
The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology (1995) 1.51
Driving performance in persons with mild senile dementia of the Alzheimer type. J Am Geriatr Soc (1993) 1.50
Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology (2001) 1.50
Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res (2000) 1.49
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Ann Neurol (1988) 1.48
Identification of new repetitive element in Leptospira interrogans serovar copenhageni and its application to PCR-based differentiation of Leptospira serogroups. J Clin Microbiol (2001) 1.48
Characterization of murine Flt4 ligand/VEGF-C. Oncogene (1997) 1.46
In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther (2001) 1.44
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1999) 1.43
On indirect genetic effects in structured populations. Am Nat (2001) 1.42
Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol (1989) 1.41
Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention. Ann Neurol (1992) 1.39
On the carcinogenicity of cadmium by the oral route. Regul Toxicol Pharmacol (1992) 1.39
Molecular evolution near a two-locus balanced polymorphism. J Theor Biol (2000) 1.39
Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab (2001) 1.38
Group selection on a quantitative character. Proc Natl Acad Sci U S A (1978) 1.38
Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol (1987) 1.38
Molecular cloning of murine FLT and FLT4. Oncogene (1993) 1.37
Progressive aphasia: a precursor of global dementia? Neurology (1990) 1.36